Pharmabiotech Stocks To Watch This Prostate Cancer Month | Latest News RSS feed

Pharmabiotech Stocks To Watch This Prostate Cancer Month - Latest News


Pharma/Biotech Stocks to Watch This Prostate Cancer Month

September is observed as National Prostate Cancer Month to raise awareness about the disease, which is the leading cause of death in men, second only to skin cancer in the United States. read more

10 Pharma Stocks To Watch This Month

Watch out for... A phase III study of 1404, a PSMA-targeted small molecule SPECT/CT imaging agent in patients with newly-diagnosed or low-grade prostate cancer, dubbed ProSPECT-AS, is underway. Top-li... read more

CGC Cooling Off, PGNX Slumps As Phase 3 Trial Flops, PLXP On Watch

(RTTNews) - The following are some of the pharma/biotech stocks that posted the biggest ... patients with newly-diagnosed or low-grade prostate cancer did not meet the co-primary endpoint of ... read more

Looking for another news?


What you need to know about beating cancer

This month ... cancer statistics—we know hearing more won’t fend off the disease or hasten your next visit to the doctor. The only information that’ll truly help you is the truth about the cancers you ... read more


Cancer Immunotherapy Treatment Market on the Rise as R&D Increases

The report indicated most of the cancer immunotherapy drugs have been used in the treatment of non-small cell lung cancer, breast cancer, and prostate cancer. Regen BioPharma, Inc. (otcqb:RGBP) earlie... read more

This Week June 20-24: Breakout Stocks to Watch and 1 Speculative Biotech

I like the long-term growth prospects of PSMT and technicals; however, my long position was not initiated until over a month after it appeared on my "Stocks to Watch This Week ... cancers such as lung ... read more

10 Takeover Targets to Watch This Fall

Last month ... ovarian cancer. Merrill Lynch analyst Tazeen Ahmad, according to 24/7 Wall St., noted that Clovis may enhance its M&A appeal to analysts this fall, as it expects to report interim data ... read more

Biopharma Companies to Watch This Week

But with the risk of failure, which could spell disaster for a stock, comes great reward as well ... PSMA-617 is a radioligand therapy for the targeted treatment of prostate cancer. Shares of Endocyte ... read more

Boston Scientific to buy Bedford company for $500m

Boston Scientific Corp., the Marlborough-based medical device giant, said Thursday it has reached a deal to buy a Bedford company that makes an injectable gel to reduce the side effects of radiation t... read more

Biotech Stocks To Watch In 2012

Exelixis (NASDAQ:EXEL) is starting to recuperate after last year's clash with the FDA regarding a registration trial for its lead agent, cabozantinib (cabo), in prostate cancer ... both had lung cance... read more

INSP Soars On Aetna Coverage, BTAI On Track, VTL Awaits Data In Sep.

The following are some of today's top gainers in the pharma/biotech ... prostate cancer and for treatment of pancreatic cancer. Clinical Trials & Near-term Catalysts: -- A Phase 1b trial of Intravenou... read more



FeedsRSS Created by. Full RSS Feed | Privacy Policy | Contact Us